Analytical Scientist Jobs in South San Francisco

Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas ..

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science.In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines ..

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, M.D., Gaddy Getz, Ph.D.and Liron Bar-Peled, ..

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science.In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines ..

Who We Are For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were ..

We are seeking a highly motivated and experienced Senior Research Associate to join the Oligonucleotides and Drug Delivery group. Through internal and externalu00A0partnerships,u00A0the Oligonucleotides and Delivery groupu00A0aims to discover new oligonucleotide ..

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science.In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines ..

RemeGen Biosciences is a biopharmaceutical company, focusing on the discovery and development of innovative biologics for the treatment of cancer and autoimmune diseases, based in South San Francisco, California, and Rockville, ..

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and ..

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, M.D., Gaddy Getz, Ph.D.and Liron Bar-Peled, ..

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and ..

... BioMarin is seeking a Principal Scientist (Team Lead/Director-level role) with extensive ... evaluating novel therapeutic approaches.The Principal Scientist will lead the research and ... early program team, the Principal..

Position SummarynParticipates in developing formulations for stable and releasable PEG-protein therapeutics. Designs and conducts pre-formulation and formulation development studies for parenteral liquid and lyophilized biologic drug products to ensure stability and ..

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science.In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines ..

Join a Team that Lives to Improve LivesrnrnPeople come to Genentech from across disciplines and across the world to solve our most challenging medical conditions. You’ll find inspiration in our passion ..

... BioMarin is seeking a Senior Scientist or Principal Scientist (Director Level) to provide nonclinical ... candidatesInteract with CROs, university laboratories, analytical laboratories, collaborators, both internal and ... BioMarin functions,..

Who We Are For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were ..

Scorpion Therapeutics is a precision oncology company founded in February 2020 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, M.D., Gaddy Getz, Ph.D.and Liron Bar-Peled, ..

Who We Are For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were ..